Aurisco Pharmaceutical Co Ltd Cash Flow Quality Index
Aurisco Pharmaceutical Co Ltd cash flow quality index. Aurisco Pharmaceutical Co Ltd (605116) has a Cash Flow Quality Index of 0.94x as of December 2024. Operating cash flow of CN¥332.41 Million is below net income of CN¥354.79 Million, suggesting accrual-heavy earnings not yet converted to cash. See Aurisco Pharmaceutical Co Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Aurisco Pharmaceutical Co Ltd (2017–2024)
Cash flow quality index of Aurisco Pharmaceutical Co Ltd from 2017 to 2024. Historical Cash Flow Quality Index for Aurisco Pharmaceutical Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Aurisco Pharmaceutical Co Ltd (605116) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Aurisco Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2017–2024)
Aurisco Pharmaceutical Co Ltd cash flow quality index by year from 2017 to 2024. Year-by-year earnings quality comparison for Aurisco Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 605116 operating cash flow.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.94x | CN¥332.41 Million | CN¥354.79 Million | ▼ -29.7% |
| 2023 | 1.33x | CN¥385.61 Million | CN¥289.42 Million | ▲ +66.7% |
| 2022 | 0.80x | CN¥166.41 Million | CN¥208.21 Million | ▼ -33.3% |
| 2021 | 1.20x | CN¥201.57 Million | CN¥168.28 Million | ▼ -12.2% |
| 2020 | 1.36x | CN¥214.48 Million | CN¥157.23 Million | ▲ +41.1% |
| 2019 | 0.97x | CN¥179.90 Million | CN¥186.13 Million | ▲ +20.5% |
| 2018 | 0.80x | CN¥109.77 Million | CN¥136.83 Million | ▼ -69.6% |
| 2017 | 2.64x | CN¥117.91 Million | CN¥44.72 Million | — |